+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prescription of Aspirin and Statins in Primary Prevention



Prescription of Aspirin and Statins in Primary Prevention



Primary Care 46(1): 13-25



The increasing burden of cardiovascular disease worldwide, including the United States, underscores the need for the more widespread use of adjunctive drug therapies of proven net benefit in the primary prevention of cardiovascular disease. These include aspirin to reduce mortality from cardiovascular disease, statins to lower LDL-cholesterol levels, appropriate use of multiple antihypertensive drug therapies to lower blood pressure, and aggressive multifactorial management of diabetes. This article reviews randomized evidence to provide guidance to primary care providers regarding the use of adjunctive drug therapies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446735

Download citation: RISBibTeXText

PMID: 30704653

DOI: 10.1016/j.pop.2018.10.004


Related references

Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?. Urologic Nursing 27(2): 166-168, 2007

Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription. Journal of the American Heart Association 8(3): E010241-E010241, 2019

Primary prevention for cardiovascular diseases: can statins replace aspirin?. Medical Principles and Practice 20(6): 584, 2012

Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data. Clinical Epidemiology 8: 123-132, 2016

A Statin a Day to Keep the Doctor Away? Comparing Aspirin and Statins for Primary Prevention of Cardiovascular Disease. Annals of PharmacoTherapy 48(9): 1238-1241, 2014

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation 121(9): 1069-1077, 2010

Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants. Journal of Hypertension 35: S33-S40, 2017

Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease. Annals of Internal Medicine 144(5): I29-I29, 2006

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Annals of Internal Medicine 144(5): 326-336, 2006

Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection. International Journal of Std and Aids 27(6): 447-452, 2016

Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study. Journal of Hypertension 35 Suppl 1: S33-S40, 2017

On the hypothetical universal use of statins in primary prevention: an observational analysis on low-risk patients and economic consequences of a potential wide prescription rate. European Journal of Clinical Pharmacology 71(4): 449-459, 2015

Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins. Digestive Diseases and Sciences 60(7): 2058-2062, 2015

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 8(): 21-21, 2007

Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease. Journal of Evaluation in Clinical Practice 23(2): 241-250, 2015